HEALTH-RELATED QUALITY OF LIFE RESULTS FROM THE PHASE III GALLIUM STUDY OF OBINUTUZUMAB-BASED AND RITUXIMAB-BASED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED INDOLENT NON-HODGKIN LYMPHOMA
Por:
Davies, A, Trask, P, Demeter, J, Florschutz, A, Hanel, M, Hong, X, Kinoshita, T, Pettengell, R, Quach, H, Robinson, S, Sadullah, S, Sancho, JM, Udvardy, M, Witzens-Harig, M, Rufibach, K, Zeuner, H and Unterhalt, M
Publicada:
26 jun 2017
Categoría:
Hematology
Resumen:
Filiaciones:
Davies, A:
Univ Southampton, Canc Res UK Ctr, Southampton, Hants, England
Trask, P:
Genentech Inc, San Francisco, CA 94080 USA
Demeter, J:
Semmelweis Univ, Budapest, Hungary
Florschutz, A:
Stadt Klinikum Dessau, Dessau Rosslau, Germany
Hanel, M:
Klinikum Chemnitz gGmbH, Chemnitz, Germany
Hong, X:
Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
Kinoshita, T:
Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
Pettengell, R:
St Georges Univ, London, England
Quach, H:
St Vincents Hosp, Melbourne, Vic, Australia
Univ Melbourne, Melbourne, Vic, Australia
Robinson, S:
Bristol Haematol & Oncol Ctr, Bristol, Avon, England
Sadullah, S:
James Paget Hosp, Great Yarmouth, England
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Udvardy, M:
Univ Debrecen, Med & Hlth Sci Ctr, Debrecen, Hungary
Witzens-Harig, M:
Uniklin Heidelberg, Heidelberg, Germany
Rufibach, K:
F Hoffmann La Roche Ltd, Basel, Switzerland
Zeuner, H:
F Hoffmann La Roche Ltd, Basel, Switzerland
Unterhalt, M:
Ludwig Maximilians Univ Munchen, Munich, Germany
|